- Open Access
Bidirectional modulation of hyperalgesia via the specific control of excitatory and inhibitory neuronal activity in the ACC
© Kang et al. 2015
- Received: 17 November 2015
- Accepted: 19 November 2015
- Published: 2 December 2015
Neurons in the anterior cingulate cortex (ACC) are assumed to play important roles in the perception of nociceptive signals and the associated emotional responses. However, the neuronal types within the ACC that mediate these functions are poorly understood. In the present study, we used optogenetic techniques to selectively modulate excitatory pyramidal neurons and inhibitory interneurons in the ACC and to assess their ability to modulate peripheral mechanical hypersensitivity in freely moving mice. We found that selective activation of pyramidal neurons rapidly and acutely reduced nociceptive thresholds and that this effect was occluded in animals made hypersensitive using Freund's Complete Adjuvant (CFA). Conversely, inhibition of ACC pyramidal neurons rapidly and acutely reduced hypersensitivity induced by CFA treatment. A similar analgesic effect was induced by activation of parvalbumin (PV) expressing interneurons, whereas activation of somatostatin (SOM) expressing interneurons had no effect on pain thresholds. Our results provide direct evidence of the pivotal role of ACC excitatory neurons, and their regulation by PV expressing interneurons, in nociception.
- Anterior Cingulate Cortex
- Excitatory Neuron
- Nociceptive Response
- Mechanical Threshold
- Anterior Cingulate Cortex Activation
The role of the anterior cingulate cortex (ACC) in pain conditions has been consistently demonstrated for the past several decades [1, 2]. Human brain imaging studies report responses of the ACC, and related cortical areas, to acute nociceptive stimuli [3–6]. Moreover, surgical lesions of the cingulate cortex (cingulotomy) reduced the unpleasantness of pain [7–10]. Given the important role of ACC in pain, numerous animal studies have been performed in this region to reveal the pathways and molecular mechanism of nociception and chronic pain [11–13]. For example, lesioning of rat ACC, similar to human cingulotomy, reduced aversive behavior during the conditioned place aversion test , and escape/avoidance test . Numerous electrophysiological studies have also observed increased activation of the ACC in both acute and chronic pain situations. For example, an acute nociceptive stimulus in the peripheral region increased firing of ACC pyramidal neurons whereas a brush stroke had minimal effect [16–18]. Peripheral injury induced long-term potentiation (LTP) of excitatory synaptic responses in the ACC neurons [19, 20]. Pharmacological inhibition or genetic deletion of LTP related molecules in the ACC reduced pain in chronic models [21–24]. Furthermore, using pharmacological manipulations and electrical stimulation within the ACC, it has been shown that ACC activation can elicit aversive behaviors [25, 26]. Yet, the spatiotemporal precision of ACC neuronal activity in pain remains enigmatic and the function of different ACC neuronal subtypes is controversial.
Optogenetic tools are increasingly being used to identify the neural circuits underlying various types of behaviors or to reveal the functions of specific subtypes of cells [27, 28]. Several cre line mice are available for the selective manipulation of specific cell types [29, 30]. However, these methods have only just started to be applied to the understanding of pain pathways. Studies to date have been performed in peripheral regions , brain stem , medial prefrontal cortex (mPFC) [33–35] and ACC [36, 37]. The two optogenetic studies in the ACC used Thy1-ChR2 mice which expresses ChR2 indiscriminately within excitatory and inhibitory neurons. One group reported that activation of ACC showed anxiodepressive-like behaviors but no change in pain . However, the other group observed an alleviation of acute inflammatory pain  which they attributed to the activation of inhibitory interneurons. The reason for these discrepant results is unknown.
In the present study, we used optogenetics and cre- expressing mouse lines to, for the first time, specifically manipulate the activity of excitatory neurons and interneurons within the ACC to establish whether specific neuronal subtypes within this brain region can acutely modulate nociceptive responses. We injected channelrhodopsin-2 (ChR2) or halorhodopsin (eNpHR3.0) carrying adeno-associated virus (AAV) in CaMKII-cre mice to activate or inhibit, respectively, the CAMKII-expressing ACC excitatory neurons. We also injected ChR2 into PV-cre or SOM-cre mice to activate specific PV positive or SOM positive interneurons. We found that activation of ACC pyramidal neurons decreased the basal mechanical threshold but did not further decrease the level in CFA-treated mice. In contrast, inhibition of these neurons reversed the effects of CFA treatment without affecting the basal mechanical threshold. Moreover activation of PV-type interneurons, but not SOM-type interneurons, also alleviated the CFA-induced pain hypersensitivity. These results show that excitatory neurons within the ACC are both necessary and sufficient for nociceptive processing and that they are under tight regulation by PV-expressing interneurons. These results suggest that ACC excitatory neurons are one of the critical mediators of nociception.
Adult (8–12 week old) male CaMKII-, PV- or SOM- cre mice (Jackson Laboratory) were used. All animals were housed under a 12 h light/dark cycle with food and water provided ad libitum. All works were conducted according to the policy and regulation for the care and use of laboratory animals approved by Institutional Animal Care and Use Committee at Seoul National University.
Stereotaxic virus injection, optic cannula implantation
AAV carrying DIO-ChR2-EYFP, DIO-eNPHR3.0-EYFP or DIO-EYFP constructs was injected into 6 week-old CaMKII-cre hetero male mice. PV-cre hetero and SOM-cre hetero or wild-type littermates (control) were also injected with AAV-DIO-ChR2-EYFP. Mice were anesthetized with an intraperitoneal injection of ketamine-xylazine (0.1 mg per gram body weight ketamine, 0.01 mg per gram body weight xylazine) and the head was fixed in a stereotaxic apparatus (Kopf Instruments, Tujunga, CA, USA). A small craniotomy was performed and, five holes were drilled. Two holes were drilled bilaterally between the hippocampus and cerebellum for screw implantation. The other three holes were drilled for virus injection and optic cannula implantation in the ACC. The virus was delivered using a 10 μl syringe (Hamilton) and a 30 gauge metal needle. The injection volume and flow rate (0.5 μl at 0.1 μl/min) were controlled by an injection pump (WPI). Virus was injected into both side of the ACC (anteroposterior [AP] + 1.0 mm from bregma, mediolateral [ML] ± 0.35 mm, dorsoventral [DV] −2.2 mm). After injection, the needle was left for additional 7 min and then was slowly removed. The optic cannula (MFC_200/230-0.39_2mm_ZF1.25_FLT, Doric Lenses., Quebec, Canada) was implanted between the virus injection site (AP + 1.0 mm from bregma, ML + 0 mm, DV – 1.25 mm). The optic cannula was then fixed with dental cement.
Electrical von Frey system for checking the mechanical threshold
A pre-test was done 3 weeks after the surgery and CFA (1:1 mixture with saline) or saline 10 μl was injected in the hind paw after the test. 3 days later the post-test was performed. In each test, there were three light ‘off’ and two light ‘on’ sessions (off1-on1-off2-on2-off3, 5 min intersession interval). Paw withdrawal threshold was measured with the electronic von Frey system. The averages of three values were calculated as the threshold of that session. 593 nm light was given continuously in an intensity of 7–9 mW/cm2. 473 nm light was given at 10 Hz (40 ms pulse) throughout the ‘on’ period for the CaMKII-cre mice. PV-cre and SOM-cre mice were given 473 nm light in 300 ms pulses with 2 s inter-pulse intervals. An intensity of 20–25 mW/cm2 at fiber tip was used in all ChR2 experiments.
Open field test
Mice were exposed for 15 min to the open field apparatus under dim light. The open field was a square opaque white box (40 × 40 × 40 cm) in which mice were monitored with a tracking program (EthoVision 3.1, Noldus, Netherlands). Light stimulation was given throughout the experiment.
Patch clamp recording
For whole-cell patch clamp recording, 300 μm thick coronal slices of ACC were prepared with a Leica VT-1000S slicer and incubated in artificial cerebrospinal fluid (aCSF) at 25 ~ 26 °C for 1 h. The aCSF comprised 124 mM NaCl, 2.5 mM KCl, 1 mM NaH2PO4, 25 mM NaHCO3, 10 mM Glucose, 2 mM CaCl2, 2 mM MgSO4 was used for the incubation and bath solution. The bath solution was oxygenated with 95 % CO2, 5 % O2 mixed gas and perfused 2 ml/min at 25 ~ 26 °C (TC-324B, Warner). The slices were transferred to the recording chamber of a BX51WI microscope (Olympus) and visualized with a ProgRes MFcool CCD camera.
For current-clamp recording, the borosilicate glass recording pipettes were filled with internal solution containing 145 mM K-gluconate, 5 mM NaCl, 0.2 mM EGTA, 10 mM HEPES, 2 mM MgATP, 0.1 mM Na3GTP, 1 mM MgCl2 (pH 7.2 with KOH, 280 ~ 290 mOsm). For current injection, pyramidal neurons in layer 2/3 were current clamped and 20 pA-140 pA depolarizing current was injected for 10 s while 473 nm light was delivered to the ACC area using a 300 ms pulse width and 2 s inter-pulse interval. For pulse train experiments, pyramidal neurons in layer 2/3 were current clamped and 2 Hz depolarizing current pulses (80 pA pulse with 200 ms width) were injected for 90 s. 473 nm light was delivered to the ACC area using 300 ms pulses with a 2 s inter-pulse interval for 30 s in the middle of the trains.
After 3 weeks of recovery, the mice was anesthetized with urethane (Sigma, 0.13 g/100 g) injection and the head was fixed in a stereotaxic apparatus (Kopf Instruments, Tujunga, CA, USA). A small craniotomy was performed and two holes were drilled above the ACC on each side of the brain (AP + 1.0 mm from bregma, ML ± 0.0 mm) and a third was drilled in the cerebellum for reference. A customized optrode, composed of a tungsten electrode (A-M Systems, USA) and optic cannula (MFC_200/230-0.39_50mm_ZF1.25_FLT, Doric lenses, USA), was inserted into the ACC for multiunit recording. Neural activity was amplified 1000 fold and digitized (sampled at 32 kHz, filtered at 600–6000 Hz) using a Digital Lynx data acquisition system (Neuralynx).
All data are presented as mean ± SEM. Statistical comparisons were made using the t-test, one-way and two-way ANOVA by SigmaPlot 11.0. The post hoc Bonferroni test was used for further comparison. If the data did not pass the equal variance test, one way ANOVA was done in ranks and Dunn’s method was used for post-hoc test. In all cases, statistical significance was indicated by *p < 0.05.
Discrete cellular population in the ACC and manipulation of the excitatory neurons
We next tested the effectiveness of the rhodopsins in pyramidal neurons within the ACC. AAV-DIO-eNpHR3.0, AAV-DIO-ChR2 or AAV-DIO-EYFP were injected into the ACC of CaMKII-cre mice and multiunit in vivo recording using an optrode was performed 3 weeks later. Activation of ChR2 with blue (473 nm) light stimulated the ACC neurons whereas activation of eNpHR3.0 with yellow (593 nm) light inhibited their activity (Fig. 1b).
Activation of excitatory neurons in the ACC decreases the mechanical threshold
Activation of ACC excitatory neurons has no effect in chronic pain conditions
To test the effects of ChR2 activation on locomotion and anxiety we performed an open field test (OFT). We found that there were no difference between the CaMKII-EYFP and CaMKII-ChR2 groups in the OFT when light was given throughout the experiment. (Additional file 4: Figure S4A). These results identify excitatory ACC neurons as effectors of pain responses and show that their activation alone is sufficient for a significant alteration in the mechanical pain threshold.
Inhibition of excitatory neurons in the ACC reverses the effects of inflammatory pain
To test for the specificity of excitatory neurons within the ACC for the modulation of the pain threshold, we examined the effects of light on CaMKII-eNpHR neurons within the restrospenial cortex (RSG), a region adjacent to the ACC. In contrast to the ACC, yellow light had no effect on pain thresholds (Additional file 5: Figure S5). These result shows that transient inhibition of excitatory neurons in the ACC can significantly reverse the enhanced sensitivity to a mechanical stimulus caused by inflammation. This suggests, therefore, that excitatory neurons in the ACC may be effectors of the sensation of pain.
Optogenetic activation of inhibitory neurons in the ACC reverses the effects of inflammatory pain
In contrast to the effects of activation of PV+ interneurons, there was no effect of the illumination of SOM-ChR2 expressing neurons on the mechanical threshold either before (off: 5.11 ± 0.15 g, on: 4.95 ± 0.11 g; n = 12) or after CFA treatment (off: 3.32 ± 0.16 g, on: 3.30 ± 0.13 g; n = 12; Fig. 5d, Additional file 7: Figure S7). The whole-cell patch-clamp experiments also showed minimal effect of optogenetic excitation of SOM+ interneurons on the activity of ACC pyramidal neurons (Fig. 5e, f). These results show that the selective activation of PV+ interneurons, but not SOM+ interneurons, in the ACC is able to reverse the effects of inflammation on the mechanical pain threshold, without affecting the mechanical pain threshold under basal conditions.
In the present study, we have demonstrated that neurons within the ACC are acutely involved in the nociceptive responses of painful stimuli. We found that the specific activation of excitatory neurons in the ACC results in a lowering of the mechanical pain threshold, which is consistent with the view that the ACC is important in nociceptive responses [1, 2, 12, 16]. Interestingly, the effect occurred rapidly upon optogenetic excitation, was rapidly reversible upon termination of illumination and was reproducible upon a second trial. This strongly suggests that these ACC neurons are effectors of the nociceptive responses as opposed to being a secondary reporter of the stimulus. This may be due to activating the descending facilitation projection . Of course, our findings do not exclude the possibility that there are other primary mediators of the nociceptive responses. However, the observation that simply exciting a proportion of excitatory neurons in the ACC was able to significantly modify the mechanical pain threshold demonstrates the key role played by these neurons.
The observation that optogenetic excitation of excitatory ACC neurons was unable to further lower the mechanical pain threshold in mice treated with CFA suggests an occlusion between the two effects. In other words, an increase in activity in these ACC neurons may be mediating the nociceptive responses of inflammatory pain. If this is the case, the prediction would be that optogenetic inhibition of this neuronal may reverse the effects of inflammation on the mechanical pain threshold. The finding that optogenetic inhibition of excitatory ACC neurons had a substantial effect on the mechanical threshold after CFA treatment strongly suggests that these neurons do indeed convey this nociceptive signal. Interestingly, optogenetic inhibition of these neurons had no effect under normal (non-inflammatory) conditions. Thus, an increase in activity of this neuronal population signals the hyperalgesic state. When considered together these results imply that excitatory neurons in the ACC are both necessary and sufficient to mediate sensitization to mechanical stimuli.
Excitatory neurons in the cortex are under strong regulation by GABAergic interneurons. We found that optogenetic stimulation of one class, PV-containing interneurons, was sufficient to have a substantial effect on the pain threshold. This effect was again specific for the inflamed state. Indeed, in all respects, stimulation of this single interneuron class mimicked the effects of inhibition of the excitatory neurons within this brain structure. This observation is consistent with the role of PV+ interneurons as mediators of powerful feed-forward inhibition of pyramidal neurons . It shows that excitatory ACC neurons are under powerful influence of this interneuronal subclass during painful stimuli and that their specific activation is sufficient to alleviate mechanical hypersensitivity, presumably by their inhibition of pyramidal neurons in the ACC. Recently, an opposite conclusion has been reached with respect to the role of the mPFC, especially the prelimbic cortex (PL), in the processing of painful information. Activation of PL excitatory neurons reduced pain , and activation of PV interneurons induced more pain . Moreover, activation of PL projection to nucleus accumbens relieved pain . These results highlight how anatomically distinct cortical regions have discrete roles in pain processing.
Recently two other studies have used optogenetic approaches to address specifically the functional roles of the ACC but they drew different conclusions. In one study it was reported that optogenetic stimulation of Thy1-ChR2 mice did not affect the mechanical threshold  whereas in the other study it was reported that activation of Thy1-ChR2 mice resulted in analgesia . Why the two studies reached different conclusions is unclear, though it may be due to the use of different Thy1-ChR2 mice lines. There are several possibilities why our conclusions differs from the study of Barthas et al. . Firstly, in the Thy1 mouse there is expression of ChR2 in multiple neuronal types. Indeed, we found that specific activation of ChR2 in pyramidal neurons and PV+ interneurons had diametrically-opposed effects. Secondly, in this previous study, optogenetic stimulation and the mechanical threshold test were not performed at the same time. Therefore, this raises the possibility that chronic activation of ACC excitatory neurons does not affect the mechanical threshold but rather this requires their acute activation. Our study does, however, agree with the report of Gu et al. , which attributed the analgesia to the activation of inhibitory neurons, and extends these findings by identifying PV+ neurons as a critical inhibitory neuronal class.
In the study by Barthas et al.  it was reported that optogenetic stimulation resulted in a long lasting alterations in anxiety and depressive-like behaviors . In the present study we did not observe any effects of optogenetic manipulation on anxiety-like behavior, as assessed using the open field test. This difference could be explained by the need for repeated stimulation to elicit mood-related behaviors and/or because in the Thy1-ChR2 mice mixed cell types are affected.
In conclusion, we have identified two specific neuronal types within the ACC that are involved in the nociceptive responses to inflammatory pain. These results raise the possibility that specifically targeting these neuronal populations may lead to effective treatments of painful states.
This work was supported by the Ministry of Education, Science and Technology in Korea through National Research Foundation (R32-10142). S.J.K. was supported by BK21 fellowship. B.-K.K. is a supported by the National Honor Scientist Program of Korea. MZ supported by Canada Research Chair, and Canadian Institute for Health Research operating grants (MOP-124807) and NSERC Discovery Grant (RGPIN 402555). GLC was supported by the MRC (UK).
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Vogt BA. Pain and emotion interactions in subregions of the cingulate gyrus. Nat Rev Neurosci. 2005;6:533–44.PubMed CentralView ArticlePubMedGoogle Scholar
- Zhuo M. Cortical excitation and chronic pain. Trends Neurosci. 2008;31:199–207.View ArticlePubMedGoogle Scholar
- Dunckley P, Wise RG, Aziz Q, Painter D, Brooks J, Tracey I, et al. Cortical processing of visceral and somatic stimulation: differentiating pain intensity from unpleasantness. Neuroscience. 2005;133:533–42.View ArticlePubMedGoogle Scholar
- Peyron R, Laurent B, Garcia-Larrea L. Functional imaging of brain responses to pain. A review and meta-analysis (2000). Neurophysiol Clin. 2000;30:263–88.View ArticlePubMedGoogle Scholar
- Strigo IA, Duncan GH, Boivin M, Bushnell MC. Differentiation of visceral and cutaneous pain in the human brain. J Neurophys. 2003;89:3294–303.View ArticleGoogle Scholar
- Talbot JD, Marrett S, Evans AC, Meyer E, Bushnell MC, Duncan GH. Multiple representations of pain in human cerebral cortex. Science. 1991;251:1355–8.View ArticlePubMedGoogle Scholar
- Pillay PK, Hassenbusch SJ. Bilateral MRI-guided stereotactic cingulotomy for intractable pain. Stereotact Funct Neurosurg. 1992;59:33–8.View ArticlePubMedGoogle Scholar
- Wong ET, Gunes S, Gaughan E, Patt RB, Ginsberg LE, Hassenbusch SJ, et al. Palliation of intractable cancer pain by MRI-guided cingulotomy. Clin J Pain. 1997;13:260–3.View ArticlePubMedGoogle Scholar
- Yen CP, Kuan CY, Sheehan J, Kung SS, Wang CC, Liu CK, et al. Impact of bilateral anterior cingulotomy on neurocognitive function in patients with intractable pain. J Clin Neurosci. 2009;16:214–9.View ArticlePubMedGoogle Scholar
- Yen CP, Kung SS, Su YF, Lin WC, Howng SL, Kwan AL. Stereotactic bilateral anterior cingulotomy for intractable pain. J Clin Neurosci. 2005;12:886–90.View ArticlePubMedGoogle Scholar
- Zhuo M. Cortical plasticity as a new endpoint measurement for chronic pain. Mol Pain. 2011;7:54.PubMed CentralView ArticlePubMedGoogle Scholar
- Fuchs PN, Peng YB, Boyette-Davis JA, Uhelski ML. The anterior cingulate cortex and pain processing. Front Integr Neurosci. 2014;8:35.PubMed CentralView ArticlePubMedGoogle Scholar
- Shyu BC, Vogt BA. Short-term synaptic plasticity in the nociceptive thalamic-anterior cingulate pathway. Mol Pain. 2009;5:51.PubMed CentralView ArticlePubMedGoogle Scholar
- Johansen JP, Fields HL, Manning BH. The affective component of pain in rodents: direct evidence for a contribution of the anterior cingulate cortex. Proc Nat Acad Sci U S A. 2001;98:8077–82.View ArticleGoogle Scholar
- LaGraize SC, Labuda CJ, Rutledge MA, Jackson RL, Fuchs PN. Differential effect of anterior cingulate cortex lesion on mechanical hypersensitivity and escape/avoidance behavior in an animal model of neuropathic pain. Exp Neurol. 2004;188:139–48.View ArticlePubMedGoogle Scholar
- Koga K, Li X, Chen T, Steenland HW, Descalzi G, Zhuo M. In vivo whole-cell patch-clamp recording of sensory synaptic responses of cingulate pyramidal neurons to noxious mechanical stimuli in adult mice. Mol Pain. 2010;6:62.PubMed CentralView ArticlePubMedGoogle Scholar
- Shyu BC, Chen WF, Shih HC. Electrically and mechanically evoked nociceptive neuronal responses in the rat anterior cingulate cortex. Acta Neurochir Suppl. 2008;101:23–5.View ArticlePubMedGoogle Scholar
- Sikes RW, Vogt BA. Nociceptive neurons in area 24 of rabbit cingulate cortex. J Neurophys. 1992;68:1720–32.Google Scholar
- Wei F, Zhuo M. Potentiation of sensory responses in the anterior cingulate cortex following digit amputation in the anaesthetised rat. J Physiol. 2001;532:823–33.PubMed CentralView ArticlePubMedGoogle Scholar
- Xu H, Wu LJ, Wang H, Zhang X, Vadakkan KI, Kim SS, et al. Presynaptic and postsynaptic amplifications of neuropathic pain in the anterior cingulate cortex. J Neurosci. 2008;28:7445–53.PubMed CentralView ArticlePubMedGoogle Scholar
- Li XY, Ko HG, Chen T, Descalzi G, Koga K, Wang H, et al. Alleviating neuropathic pain hypersensitivity by inhibiting PKMzeta in the anterior cingulate cortex. Science. 2010;330:1400–4.View ArticlePubMedGoogle Scholar
- Wang H, Xu H, Wu LJ, Kim SS, Chen T, Koga K, et al. Identification of an adenylyl cyclase inhibitor for treating neuropathic and inflammatory pain. Sci Transl Med. 2011;3:65ra63.Google Scholar
- Wei F, Qiu CS, Kim SJ, Muglia L, Maas JW, Pineda VV, et al. Genetic elimination of behavioral sensitization in mice lacking calmodulin-stimulated adenylyl cyclases. Neuron. 2002;36:713–26.View ArticlePubMedGoogle Scholar
- Wu LJ, Toyoda H, Zhao MG, Lee YS, Tang J, Ko SW, et al. Upregulation of forebrain NMDA NR2B receptors contributes to behavioral sensitization after inflammation. J Neurosci. 2005;25:11107–16.View ArticlePubMedGoogle Scholar
- Calejesan AA, Kim SJ, Zhuo M. Descending facilitatory modulation of a behavioral nociceptive response by stimulation in the adult rat anterior cingulate cortex. Eur J Pain. 2000;4:83–96.View ArticlePubMedGoogle Scholar
- Chen T, Wang W, Dong YL, Zhang MM, Wang J, Koga K, et al. Postsynaptic insertion of AMPA receptor onto cortical pyramidal neurons in the anterior cingulate cortex after peripheral nerve injury. Mol Brain. 2014;7:76.PubMed CentralView ArticlePubMedGoogle Scholar
- Tye KM, Deisseroth K. Optogenetic investigation of neural circuits underlying brain disease in animal models. Nat Rev Neurosci. 2012;13:251–66.View ArticlePubMedGoogle Scholar
- Yizhar O, Fenno LE, Davidson TJ, Mogri M, Deisseroth K. Optogenetics in neural systems. Neuron. 2011;71:9–34.View ArticlePubMedGoogle Scholar
- Van den Oever MC, Rotaru DC, Heinsbroek JA, Gouwenberg Y, Deisseroth K, Stuber GD, et al. Ventromedial prefrontal cortex pyramidal cells have a temporal dynamic role in recall and extinction of cocaine-associated memory. J Neurosci. 2013;33:18225–33.PubMed CentralView ArticlePubMedGoogle Scholar
- Wolff SB, Grundemann J, Tovote P, Krabbe S, Jacobson GA, Muller C, et al. Amygdala interneuron subtypes control fear learning through disinhibition. Nature. 2014;509:453–8.View ArticlePubMedGoogle Scholar
- Iyer SM, Montgomery KL, Towne C, Lee SY, Ramakrishnan C, Deisseroth K, et al. Virally mediated optogenetic excitation and inhibition of pain in freely moving nontransgenic mice. Nat Biotechnol. 2014;32:274–8.PubMed CentralView ArticlePubMedGoogle Scholar
- Hickey L, Li Y, Fyson SJ, Watson TC, Perrins R, Hewinson J, et al. Optoactivation of locus ceruleus neurons evokes bidirectional changes in thermal nociception in rats. J Neurosci. 2014;34:4148–60.PubMed CentralView ArticlePubMedGoogle Scholar
- Lee M, Manders TR, Eberle SE, Su C, D'Amour J, Yang R, et al. Activation of corticostriatal circuitry relieves chronic neuropathic pain. J Neurosci. 2015;35:5247–59.PubMed CentralView ArticlePubMedGoogle Scholar
- Wang GQ, Cen C, Li C, Cao S, Wang N, Zhou Z, et al. Deactivation of excitatory neurons in the prelimbic cortex via Cdk5 promotes pain sensation and anxiety. Nat Commun. 2015;6:7660.PubMed CentralView ArticlePubMedGoogle Scholar
- Zhang Z, Gadotti VM, Chen L, Souza IA, Stemkowski PL, Zamponi GW. Role of Prelimbic GABAergic Circuits in Sensory and Emotional Aspects of Neuropathic Pain. Cell Rep. 2015;12:752–9.View ArticlePubMedGoogle Scholar
- Barthas F, Sellmeijer J, Hugel S, Waltisperger E, Barrot M, Yalcin I. The anterior cingulate cortex is a critical hub for pain-induced depression. Biol Psychiatry. 2015;77:236–45.View ArticlePubMedGoogle Scholar
- Gu L, Uhelski ML, Anand S, Romero-Ortega M, Kim YT, Fuchs PN, et al. Pain inhibition by optogenetic activation of specific anterior cingulate cortical neurons. PloS One. 2015;10, e0117746.PubMed CentralView ArticlePubMedGoogle Scholar
- Chen T, Koga K, Descalzi G, Qiu S, Wang J, Zhang LS, et al. Postsynaptic potentiation of corticospinal projecting neurons in the anterior cingulate cortex after nerve injury. Mol Pain. 2014;10:33.PubMed CentralView ArticlePubMedGoogle Scholar
- Delevich K, Tucciarone J, Huang ZJ, Li B. The Mediodorsal Thalamus Drives Feedforward Inhibition in the Anterior Cingulate Cortex via Parvalbumin Interneurons. J Neurosci. 2015;35:5743–53.PubMed CentralView ArticlePubMedGoogle Scholar